Before you participate in this activity, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. 

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.

Question Title

* 1. Where are you in your career? 

Question Title

* 2. 28 y/o female with Crohn's Colitis, was previously controlled on adalimumab; now with loss of response due to anti-drug antibodies. She also has a history of psoriasis that is now flaring again off adalimumab. She plans to get pregnant in the next 1-2 years.

Which therapy/MOA would be most effective and desirable in this context?

Question Title

* 3. In VIVID-2 extension, what percentage of patients with Crohn’s disease who achieved endoscopic response to Mirikizumab at week 52 maintained that response at year 2?

Question Title

* 4. Completing this pre-survey does not qualify you for a CME certificate. Only after completing the post-survey & evaluation form will a certificate be issued.

🔗 Proceed to activity on X/MondayNightIBD
🔗 Proceed to activity post-survey
(post-survey completion must occur on or after activity launch date and prior to activity expiration date to be valid for claiming credit)
( Privacy & Cookie Notice

T